<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Wednesday February 17th 2021 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2021-02-17" ></link>
<id>urn:uuid:d0141180-a463-54a3-dcf3-7ea18c2bc5b9</id>
<updated>2026-04-24T13:33:12-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ADPT: GOEL DAVID E (DIR) Acquired (JB) 1,504 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 2/15</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5250448" ></link>
<id>urn:uuid:f86c0d5d-beb7-26cc-806e-89df669f4762</id>
<updated>2021-02-17T21:40:28-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $14.06. Mkt Cap:2.2B. 10D Vol: 1.7mm]]></summary>
</entry>
<entry>
<title>ARES: ROSENTHAL BENNETT (F,CB,DIR) Sold (AS) 114,637 Shares of ARES MANAGEMENT CORP for $52.36-$53.14 on 2/16-2/17</title>
<link href="http://www.insiderinsights.com/company/ares/ares-management-corp/id-5250262" ></link>
<id>urn:uuid:8a764367-ebeb-3642-bd8d-a61bcd0e61ed</id>
<updated>2021-02-17T20:39:20-05:00</updated>
<summary type="html" ><![CDATA[ARES MANAGEMENT CORP (ARES). Recent Price: $115.61. Mkt Cap:26.1B. 10D Vol: 3.5mm]]></summary>
</entry>
<entry>
<title>ADPT: DOBMEIER ERIC (DIR) Acquired (JB) 1,504 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 2/14</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5250123" ></link>
<id>urn:uuid:1974770e-12da-033b-4821-a1e01fca2685</id>
<updated>2021-02-17T20:01:21-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $14.06. Mkt Cap:2.2B. 10D Vol: 1.7mm]]></summary>
</entry>
<entry>
<title>ADPT: LO FRANCIS (HR) Exercised 2k Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $7.80 on 2/16, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5250105" ></link>
<id>urn:uuid:8beb1b64-c542-32f9-739f-0e38731a3246</id>
<updated>2021-02-17T20:01:16-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $14.06. Mkt Cap:2.2B. 10D Vol: 1.7mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR) Exercised 30k Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $6.55 on 2/12-2/16, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5250130" ></link>
<id>urn:uuid:8facf5da-2c15-efdc-430c-7937e903fdd3</id>
<updated>2021-02-17T20:01:11-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $14.06. Mkt Cap:2.2B. 10D Vol: 1.7mm]]></summary>
</entry>
<entry>
<title>ADPT: TAYLOR STACY L (VP,GC) Exercised 16,250 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $31.71 on 2/16, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5250128" ></link>
<id>urn:uuid:df134087-a8ad-97c2-6257-abe9f28b00c3</id>
<updated>2021-02-17T20:01:11-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $14.06. Mkt Cap:2.2B. 10D Vol: 1.7mm]]></summary>
</entry>
<entry>
<title>ADPT: BENZENO SHARON (BD) Exercised 16,250 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $31.71 on 2/16, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5250107" ></link>
<id>urn:uuid:8d27b073-b0c2-1b77-6340-d6a6cc7362cd</id>
<updated>2021-02-17T20:01:06-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $14.06. Mkt Cap:2.2B. 10D Vol: 1.7mm]]></summary>
</entry>
</feed>